$0.186
-0.011 (-5.92%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de MTNB por análisis de gráficos similares
Alphio's MTNB stock price prediction model matches the current Matinas BioPharma Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.19 (-0.17%). The 1-week path is $0.19 (+0.88%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Matinas BioPharma Holdings Inc?
Matinas BioPharma Holdings Inc is not a good buy right now due to its declining financial health and significant operational challenges. The current price is $0.20, and the company has reported a staggering year-to-date change of -67.74%. Additionally, the RSI is at 38.803, indicating that the stock is in a bearish trend. The company has also faced compliance challenges with the NYSE due to stockholders' equity falling below $4 million, which is a significant risk. Furthermore, the forward P/E ratio is 0, indicating no expected earnings growth, and the company has reported consistent losses, with a net income of -$4.27 million in Q3 2024. Overall, the combination of these factors suggests that now is not the right time to invest in this asset.
MTNB cerró en $0.19 el Wednesday, tras bajar -5.92%
Matinas BioPharma Holdings Inc (MTNB) last closed at $0.186, losing -5.92%. These facts feed the 1-day and 1-week MTNB price prediction above.
Consenso de analistas
Matinas BioPharma Holdings Inc (MTNB): 3 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Matinas BioPharma Holdings Inc (MTNB) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de MTNB, ordenadas por similitud.
Análisis de estacionalidad de MTNB
Historically the probability of a positive September return for MTNB is 47.73%. June offers the highest probability of a positive month at 65.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de MTNB
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $1.02 | $1.16 | $1.21 | +523.23% |
| Oct 2026 | $0.91 | $0.96 | $1.17 | +413.51% |
| Nov 2026 | $0.84 | $0.86 | $1.08 | +360.65% |
| Dec 2026 | $0.95 | $1.00 | $1.12 | +438.82% |
En 2026, se proyecta que Matinas BioPharma Holdings Inc (MTNB) oscile entre $0.84 y $1.21.
Previsión mensual de Matinas BioPharma Holdings Inc para 2026
En Sep de 2026, se proyecta que Matinas BioPharma Holdings Inc promedie $1.16, con un mínimo de $1.02 y un máximo de $1.21.
En Oct de 2026, se proyecta que Matinas BioPharma Holdings Inc promedie $0.96, con un mínimo de $0.91 y un máximo de $1.17.
En Nov de 2026, se proyecta que Matinas BioPharma Holdings Inc promedie $0.86, con un mínimo de $0.84 y un máximo de $1.08.
En Dec de 2026, se proyecta que Matinas BioPharma Holdings Inc promedie $1.00, con un mínimo de $0.95 y un máximo de $1.12.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.